Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

cbdMD's Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $11.8 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 2.07% year-over-year to $11.8 million; the TTM value through Dec 2025 reached $43.0 million, down 14.81%, while the annual FY2025 figure was $10.4 million, 1.53% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $11.8 million at cbdMD, up from $10.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $124.9 million in Q3 2021 and bottomed at $9.9 million in Q2 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $24.6 million (2023), against an average of $43.9 million.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 12.67% in 2021 before it tumbled 67.34% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $99.3 million in 2021, then tumbled by 64.03% to $35.7 million in 2022, then plummeted by 57.75% to $15.1 million in 2023, then dropped by 23.53% to $11.5 million in 2024, then increased by 2.07% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Liabilities and Shareholders Equity are $11.8 million (Q4 2025), $10.4 million (Q3 2025), and $9.9 million (Q2 2025).